ABALAM ABACAVIR SULFATE & LAMIVUDINE TABLETS 600/300 MG
Product details
Registration number: SIN15864P
Classification: Prescription Only
Active ingredients:
- Abacavir Sulfate 702.762 mg eqv. Abacavir
- Lamivudine
Strength:
- 600.0 mg
- 300.000 mg
Dosage form: TABLET, FILM COATED
Route: ORAL
Registrant: MEDICELL PHARMACEUTICAL (S) PTE. LTD.
ATC code: J05AR02
HSA approval date: 2 December 2019
Manufacturer(s): HETERO LABS LIMITED
Manufacturing country/countries: INDIA
What are the HSA registration number and classification for ABALAM ABACAVIR SULFATE & LAMIVUDINE TABLETS 600/300 MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15864P
Classification: Prescription Only
What active ingredients and strength are recorded for ABALAM ABACAVIR SULFATE & LAMIVUDINE TABLETS 600/300 MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Abacavir Sulfate 702.762 mg eqv. Abacavir
- Lamivudine
Strength:
- 600.0 mg
- 300.000 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ABALAM ABACAVIR SULFATE & LAMIVUDINE TABLETS 600/300 MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, FILM COATED
Route: ORAL
Who is the recorded registrant for ABALAM ABACAVIR SULFATE & LAMIVUDINE TABLETS 600/300 MG?
According to the HSA dataset updated 7 August 2026:
Registrant: MEDICELL PHARMACEUTICAL (S) PTE. LTD.
Which manufacturers and countries are listed for ABALAM ABACAVIR SULFATE & LAMIVUDINE TABLETS 600/300 MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): HETERO LABS LIMITED
Manufacturing country/countries: INDIA
Where can I look up ABALAM ABACAVIR SULFATE & LAMIVUDINE TABLETS 600/300 MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15864P or the exact product name ABALAM ABACAVIR SULFATE & LAMIVUDINE TABLETS 600/300 MG. The general register link does not preselect this product.
What are the source dates for this ABALAM ABACAVIR SULFATE & LAMIVUDINE TABLETS 600/300 MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ABALAM ABACAVIR SULFATE & LAMIVUDINE TABLETS 600/300 MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15864P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)